India’s Cheaper Weight-Loss Drugs Could Transform Global Obesity Treatment
India is on the verge of a major shift in the fight against obesity, as the patent for semaglutide – the key ingredient behind blockbuster drugs like Ozempic and Wegovy – expires in the country. The development will allow Indian pharmaceutical companies to produce more affordable generic versions of the drug, potentially slashing treatment costs…
